Strides Pharma Science Ltd. agreed to acquire a 70% stake in Switzerland-based private pharmaceutical company Fair-Med Healthcare AG for CHF2.2 million.
Bengaluru, India-based Strides Pharma, which manufactures and sells generic medicines, gelatin capsules, ointments and creams, said Fair-Med's market access in Germany, Austria and Switzerland will complement its product portfolio. The acquisition will be made through subsidiary Strides Pharma Global Pte. Ltd.
Fair-Med manufactures generic medicines, including therapies for heart disorders, respiratory diseases and cancer and has a portfolio of more than 30 products.
